Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Canada's Aurinia Pharma reported Luveniq (voclosporin), a...
3SBio of Shenyang received CFDA approval...
3SBio paid $100 million for exclusive...
3SBio of Shenyang entered a strategic...
3SBio of Shenyang selected the first...
3SBio of Shenyang invested $15.2 million...
3SBio of Shenyang has invested in two...
Sunshine Guojian Pharma (Shanghai), a...
3SBio (HK:1530) of Shenyang expanded its...
Suzhou CStone Pharma out-licensed China rights for...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China